Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.
Cosentyx
Breaking News
Subscribe to VCpost newsletter
Most Popular
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
- Canadian Family Receives Wrong Remains After Father Died While on Vacation in Cuba
- Samsung to Implement Six-Day Work Week for Executives Slammed by Critics 'Not Effective'
- Baltimore Sues Dali Cargo Ship Owner and Manager for Negligence That Led to Key Bridge Collapse
- American Millionaire Charged in Brutal Murders of Canadian Tycoon and His Partner in Dominica Denied Bail
